Atlas Trials

Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas

Clinical trial NCT00822887 · COMPLETED

Trial details

NCT number
NCT00822887
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Gliomas
Start date
2007-03-01
Primary completion
2010-05-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.